首页> 美国卫生研究院文献>Journal of Pharmaceutical Health Care and Sciences >Association between vancomycin pharmacokinetic/pharmacodynamic parameters patient characteristics and mortality in patients with bacteremia caused by vancomycin-susceptible Enterococcus faecium: a single-center retrospective study
【2h】

Association between vancomycin pharmacokinetic/pharmacodynamic parameters patient characteristics and mortality in patients with bacteremia caused by vancomycin-susceptible Enterococcus faecium: a single-center retrospective study

机译:万古霉素易感肠球菌引起的菌血症患者万古霉素药代动力学/药效学参数患者特征和死亡率之间的关联:单中心回顾性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundVancomycin is commonly used to treat Enterococcus faecium (E. faecium) bacteremia. However, there are very few studies on the association between the trough concentration, area under the curve from 0 to 24 h /minimum inhibitory concentration (AUC24/MIC) ratio, and the therapeutic effect of vancomycin on E. faecium bacteremia. This study aimed to investigate the associations between vancomycin pharmacokinetic/pharmacodynamic parameters, patient characteristics, and mortality in patients with E. faecium bacteremia.
机译:背景万古霉素通常用于治疗粪肠球菌(E. faecium)菌血症。然而,关于谷浓度,0至24 h /最小抑菌浓度(AUC24 / MIC)之比的曲线下面积与万古霉素对屎肠球菌菌血症的治疗作用之间的关系的研究很少。这项研究旨在调查万古霉素药代动力学/药效学参数,患者特征和粪肠球菌菌血症患者死亡率之间的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号